CME Group
CME
Market cap $99.1B

275.08 USD

-0.11

0.04%

At close Jul 11, 4:00 PM EDT

After hours

274.35

-0.73

0.27%

1 day

-0.04%

5 days

-0.78%

1 month

2.01%

3 months

5.18%

6 months

19.89%

Year to date

18.20%

1 year

40.49%

5 years

66.51%

10 years

180.44%

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

Financials Financial Data & Stock Exchanges

0

Funds holding %

of 7,312 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

126% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 91

36% more call options, than puts

Call options by funds: $579M | Put options by funds: $427M

17% more funds holding in top 10

Funds holding in top 10: 53 [Q4 2024] → 62 (+9) [Q1 2025]

16% more capital invested

Capital invested by funds: $74.4B [Q4 2024] → $86.5B (+$12.1B) [Q1 2025]

6% more funds holding

Funds holding: 1,471 [Q4 2024] → 1,559 (+88) [Q1 2025]

6% more repeat investments, than reductions

Existing positions increased: 585 | Existing positions reduced: 551

0.1% more ownership

Funds ownership: 88.09% [Q4 2024] → 88.19% (+0.1%) [Q1 2025]

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$211

23%

downside

Avg. target

$281

2%

upside

High target

$305

11%

upside

7 analyst ratings

3 positive

43%

3 neutral

43%

1 negative

14%

Barclays Benjamin Budish	9%upside $299	Equal-Weight Maintained	10 Jul 2025
Citigroup Christopher Allen	0%downside $275	Neutral Maintained	3 Jul 2025
Oppenheimer Owen Lau	9%upside $300	Outperform Maintained	4 Jun 2025
UBS Alex Kramm	11%upside $305	Buy Maintained	25 Apr 2025
Morgan Stanley Mike Cyprys	11%upside $304	Overweight Maintained	24 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 17 articles about CME published over the past 30 days

Zacks Investment Research

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

Record Europe, Middle East and Africa (EMEA) ADV of 6.7M, up 15% in Q2 2025 Record Asia Pacific (APAC) ADV of 2.2M, up 30% in Q2 2025 LONDON and SINGAPORE , July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 9.2 million contracts in Q2 2025, up 18% year over year. Reflecting all trading reported outside the United States, this growth was driven by record quarterly ADV in EMEA and APAC.

CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

Zacks Investment Research

3 Crypto-Focused Stocks to Buy as Bitcoin Heads Toward New High

With Bitcoin holding near $109K and optimism rising, V, CME, and BLK emerge as top crypto-exposed stocks to watch now.

3 Crypto-Focused Stocks to Buy as Bitcoin Heads Toward New High

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers, and cashflow growth. Two key business segments of operating exchanges, as well as providing market data to subscribers, have seen demand growth.

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It

Inflation isn't going away. In fact, it may soon be fueled deliberately. That makes owning hard assets and top-tier dividend stocks essential. I've identified two stocks that thrive in this new reality, each built to handle inflation, deliver income, and offer long-term upside. These aren't random picks. They're special. If I could buy only two dividend stocks for what's coming, I'd seriously consider these.

If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It

Zacks Investment Research

Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?

CME is launching FX Tape+ to unify fragmented FX data into a real-time, centralized reference for global market transparency.

Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?

CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures

CHICAGO , July 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it has completed its first physical delivery cycle of Hard Red Spring Wheat futures, with 182 contracts delivered on July 1, 2025, the first delivery date since the product's April 14 launch. "Completion of the first delivery cycle is another important milestone for our new Hard Red Spring Wheat futures contract," said John Ricci, Managing Director and Global Head of Agricultural Products at CME Group.

CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures

Zacks Investment Research

4 Crypto-Centric Stocks to Watch Closely Before the Next Bitcoin Rally

As Bitcoin holds firm near $107K, CME, ACN, V, and PYPL emerge as crypto-centric stocks with growth potential in 2025.

4 Crypto-Centric Stocks to Watch Closely Before the Next Bitcoin Rally

Capitalize on Volatility: 3 Finance Stocks Thriving in 2025

Markets may hate uncertainty, but in 2025, they seem to love volatility. Despite cloudy and, at times, contradictory economic indicators, the NASDAQ and S&P 500 indices reached all-time highs to close out the second quarter.

Capitalize on Volatility: 3 Finance Stocks Thriving in 2025

CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

Record quarterly ADV of 30.2 million contracts Record quarterly ADV in interest rates, agriculture, metals and SOFR futures Record June ADV of 25.7 million contracts Record quarterly international ADV of 9.2 million contracts CHICAGO , July 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its Q2 and June 2025 market statistics, with average daily volume (ADV) reaching a new quarterly record of 30.2 million contracts and June ADV reaching a record 25.7 million contracts. In Q2, the company's ADV grew 15% year-over-year, with record quarterly volume in interest rate, agricultural and metals products.

CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

See News Rankings

Charts implemented using Lightweight Charts™